Volume 25, Issue 6 pp. 691-693
Case Reports

Preoperative Exchange Transfusion for Sickle Cell Disease Patients Undergoing Open-Heart Surgery: An Exception to the Rule

Ravindra K Adhikari M.D.

Ravindra K Adhikari M.D.

Specialist in Anesthesia

Search for more papers by this author
Madan M. Maddali M.D.

Madan M. Maddali M.D.

Senior Consultant in Anesthesia

Search for more papers by this author
Sunny Zacharias F.R.C.S.

Sunny Zacharias F.R.C.S.

Senior Consultant in Cardio Thoracic Surgery, Royal Hospital, Muscat, Sultanate of Oman

Search for more papers by this author
First published: 27 August 2010
Citations: 11
Address for correspondence: Madan M. Maddali, M.D., Department of Anesthesia, PBox.No: 1331, PC: 111, Royal Hospital, Muscat, Sultanate of Oman. Fax: 00-968-24499759; e-mail: [email protected]

Conflict of interest: There are no conflicts of interest.

Abstract

Abstract Preoperative exchange transfusion is a routine practice in patients with sickle cell disease having elevated sickle cell hemoglobin levels (>40%) undergoing open-heart surgery on cardiopulmonary bypass. A new approach toward acceptance and management of sickle cell disease patients with high sickle cell hemoglobin levels for open-heart surgery without preoperative exchange transfusion of blood is presented. (J Card Surg 2010;25:691-693)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.